Byotrol plc is a United Kingdom-based company. The Company is engaged in the development, patenting and sale of products based on microbial technology. The Company operates in three segments: being product sales, licence fees and royalties. The Company manufactures products based on microbial technology in the United Kingdom and also generates revenues from licensing agreements. Its customers are based in the United Kingdom, North America and Worldwide. The Company's operations are located in the United Kingdom and the United States of America. Its principal activity is to market and sell consumer products. The Company's wholly owned subsidiaries include Byotrol Technology Limited and Byotrol Inc, both are engaged in antimicrobial products business.